Active Digestion, Kidneys & Other Organs Heart, Stroke & Blood

Utilising longitudinal biomarker data to improve risk prediction and follow-up scheduling in patients with Chronic Kidney Disease

In plain English

AI plain-English summary

Doctors currently guess how often kidney patients need blood tests, and often schedule them too frequently or not often enough. Chronic kidney disease affects roughly one in ten UK adults, and can silently progress to kidney failure requiring dialysis or transplant. Existing risk calculators only use a patient’s most recent test results, ignoring the rich history of past measurements that could reveal whether the disease is accelerating or stable. This project will build a statistical tool that uses a patient’s entire sequence of blood and urine test results to predict their future risk of kidney failure more accurately, and then recommend the optimal date for their next appointment. If successful, the tool could replace one-size-fits-all follow-up schedules with personalised intervals—some patients might safely wait six months, while others need checking every two weeks. For the NHS, this means fewer unnecessary appointments for stable patients and earlier detection of deterioration in those at high risk, reducing emergency dialysis starts and hospital admissions. The research is applied and data-driven, drawing on existing longitudinal datasets rather than new laboratory work, so results could be integrated into clinical software within a few years.

View original technical description
Chronic kidney disease (CKD) is a condition where the kidneys do not work as well as they should. CKD may progress to kidney failure, where a person would need dialysis or a transplant to keep them alive. Blood and urine tests help doctors understand how severe a person’s condition is, and these measurements can be put into a risk calculator to determine how likely it is someone will develop kidney failure within the next few years. People with CKD should have their blood and urine tested regularly to update their risk estimates and allow for any necessary changes in treatment, however the optimal frequency and scheduling of these tests is unclear. We aim to investigate whether a tool can be built which would help doctors and patients determine the optimal time for their next follow-up appointment. We will also evaluate whether using a patient’s past test results can help improve existing risk calculators, which currently only use the most recent test results. We hope this work will assist the move towards a personalised follow-up approach for people with CKD, which we believe will increase the quality of life of CKD patients and concurrently provide economic benefits for the healthcare system.

View the original record at the funder ↗

Researchers

Becky Gordon (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Establishing predictors of long-term health outcomes in the NewKI CKD cohort
Clinical decision making in chronic kidney disease: A record linkage cohort study to develop tools to support patients, clinical staff and service planners
Modelling and Predicting CKD Progression
Refining and validating a clinical prediction score for childhood chronic kidney disease
Using markers of kidney damage to detect acute disease: understanding normal (biological) variation to realise patient benefits

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.